Molecular Partners Ag · SIX:MOLN
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reported a 5.80% stake in Molecular Partners Ag (Schedule 13G)
Event Sep 30, 2024 · Filed Jul 17, 2025
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reported a 5.80% stake in Molecular Partners Ag, 2,144,607 shares, as a passive investor on Sep 30, 2024. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 2,144,607
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.80% | 2,144,607 |
Source
Related
- Molecular Partners Ag
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
- Molecular Partners Ag shareholders
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 29, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 19, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 16, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Nov 25, 2025
- Schedule 13G · Montanova Capital, LLC · May 2, 2025